XRAY DENTSPLY SIRONA Inc. - Common Stock

NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗

$9,69

Fiyat · May 20, 2026

Temel veriler itibarıyla May 5, 2026

52 Haftlık Aralık

$9–$17

4% of range

Analist Derecelendirmesi

XRAY Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$9.69

Piyasa Değeri

$2.28B

P/E (TTM)

-3.8

EPS (TTM)

$-3.00

Gelir (TTM)

$3.68B

Temettü Verimi

5.6%

ROE

-36.4%

D/E Borç/Özsermaye

1.7

52 Haftlık Aralık

$9 – $17

XRAY Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $3.68B

2016-12-31 → 2025-12-31

Hisse Başına Kâr $-3.00

2016-12-31 → 2025-12-31

Serbest Nakit Akışı $104M

2016-12-31 → 2025-12-31

Marjlar -16.2%

2017-12-31 → 2025-12-31

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

XRAY

Akran Ortalaması

P/E (TTM)

-3.8

25.5

P/S (TTM) (F/S (TTM))

0.6

1.7

P/B (F/D)

1.7

2.6

EV / EBITDA

-60.0

—

Price / FCF (Fiyat / Serbest Nakit Akışı)

21.9

—

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

XRAY

Akran Ortalaması

Gross Margin (Brüt Kar Marjı)

50.0%

54.9%

Operating Margin (Faaliyet Kâr Marjı)

-11.5%

—

Net Profit Margin (Net Kâr Marjı)

-16.2%

-8.7%

ROA

-10.7%

-7.2%

ROE

-36.4%

-11.1%

ROIC

-14.5%

—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

XRAY

Akran Ortalaması

Debt / Equity (Borç / Öz Sermaye)

1.7

37.4

Current Ratio (Cari Oran)

1.5

2.3

Quick Ratio (Cari Oran)

0.2

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

XRAY

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

-3.0%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

-2.1%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

2.0%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

XRAY

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$-3.00

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

XRAY

Akran Ortalaması

Payout Ratio (Temettü Ödeme Oranı)

-21.4%

—

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

Temettü Verimi

5.6%

Temettü Ödeme Oranı

-21.4%

5 Yıllık Temettü CAGR

—

Ex-tarihi	Miktar
26 Aralık 2025	$0,1600
26 Eylül 2025	$0,1600
27 Haziran 2025	$0,1600
28 Mart 2025	$0,1600
27 Aralık 2024	$0,1600
27 Eylül 2024	$0,1600
28 Haziran 2024	$0,1600
27 Mart 2024	$0,1600
28 Aralık 2023	$0,1400
28 Eylül 2023	$0,1400
29 Haziran 2023	$0,1400
30 Mart 2023	$0,1400
29 Aralık 2022	$0,1250
29 Eylül 2022	$0,1250
23 Haziran 2022	$0,1250
24 Mart 2022	$0,1250
30 Aralık 2021	$0,1100
23 Eylül 2021	$0,1100
24 Haziran 2021	$0,1100
25 Mart 2021	$0,1000

XRAY Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

TUT 22 analist

Güçlü Al 4 18,2%
Al 4 18,2%
Tut 12 54,5%
Sat 1 4,5%
Güçlü Sat 1 4,5%

12 Aylık Fiyat Hedefi

15 analist · 2026-05-15

Medyan $13.00

Ortalama $13.60

← Tüm hedeflerin altında $9.69

Düşük $10.50

Yüksek $17.00

Medyan hedef $13.00 +34,2%

Ortalama hedef $13.60 +40,4%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

0.01%

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
31 Mart 2026	$0.27	$0.28	-0.01%
31 Aralık 2025	$0.27	$0.28	-0.01%
30 Eylül 2025	$0.37	$0.46	-0.09%
30 Haziran 2025	$0.52	$0.51	0.01%
31 Mart 2025	$0.43	$0.30	0.13%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
XRAY	$2.28B	-3.8	-3.0%	-16.2%	-36.4%	50.0%
QDEL	$1.99B	-1.8	-1.9%	-41.4%	-48.0%	—
MMSI	$5.24B	41.4	11.8%	8.5%	8.4%	48.7%
ICUI	$3.52B	4755.7	-6.3%	0.03%	0.03%	36.8%
MMED	—	—	—	—	—	—
HAE	$3.05B	19.1	4.0%	12.3%	19.4%	55.0%
NEOG	$1.27B	-1.2	-3.2%	-122.1%	-41.9%	47.1%
UFPT	$1.71B	25.4	19.5%	11.3%	16.9%	28.3%
STAA	$1.17B	-14.6	-23.7%	-33.6%	-23.6%	76.2%
AVNS	$522M	-7.2	1.9%	-10.4%	-9.1%	50.5%
BVS	—	22.5	-0.91%	4.0%	13.7%	68.3%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 17

XRAY için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$3.68B	$3.79B	$3.96B	$3.92B	$4.23B	$3.34B	$4.02B	$3.99B	$3.99B	$3.75B	$2.67B	$0
Cost of Revenue	$1.84B	$1.83B	$1.88B	$1.79B	$1.88B	$1.68B	$1.86B	$1.92B	$1.80B	$1.74B	$1.16B	$1.32B
Gross Profit	$1.84B	$1.96B	$2.09B	$2.13B	$2.35B	$1.66B	$2.16B	$2.07B	$2.19B	$2.00B	$1.52B	$1.60B
R&D Expense	$150M	$165M	$184M	$174M	$171M	$123M	$143M	$161M	$152M	$128M	$75M	$81M
SG&A Expense	$1.44B	$1.60B	$1.61B	$1.59B	$1.55B	$1.30B	$1.59B	$1.72B	$1.67B	$1.52B	$1.08B	$1.14B
Operating Income	$-422M	$-879M	$-85M	$-937M	$608M	$-3M	$353M	$-958M	$-1.56B	$455M	$375M	$446M
Interest Expense	·	·	$81M	$65M	$61M	$48M	$30M	$37M	$38M	$36M	$56M	$47M
Interest Income	·	·	·	·	·	$1M	$2M	$2M	$2M	$2M	$2M	$6M
Other Non-op	$24M	$12M	$-9M	$-53M	$-2M	$-1M	$12M	$35M	$-5M	$20M	$8M	$100.0K
Pretax Income	$-486M	$-936M	$-175M	$-1.05B	$545M	$-50M	$338M	$-958M	$-1.60B	$441M	$330M	$404M
Income Tax	$112M	$-26M	$-43M	$-105M	$134M	$23M	$82M	$53M	$-53M	$10M	$77M	$81M
Net Income	$-598M	$-910M	$-132M	$-950M	$411M	$-73M	$256M	$-1.01B	$-1.55B	$430M	$251M	$323M
EPS (Basic)	$-3.00	$-4.48	$-0.62	$-4.41	$1.88	$-0.33	$1.15	$-4.51	$-6.76	$1.97	$1.79	$2.28
EPS (Diluted)	$-3.00	$-4.48	$-0.62	$-4.41	$1.87	$-0.33	$1.14	$-4.51	$-6.76	$1.94	$1.76	$2.24
Shares (Basic)	199,400,000	203,200,000	212,000,000	215,500,000	218,400,000	219,200,000	223,100,000	224,300,000	229,400,000	218,000,000	140,000,000	141,700,000
Shares (Diluted)	199,400,000	203,200,000	212,000,000	215,500,000	220,200,000	219,200,000	224,400,000	224,300,000	229,400,000	221,600,000	142,500,000	144,200,000
EBITDA	$-70M	$-530M	$258M	$-609M	$955M	$322M	$684M	$-627M	$-1.25B	$726M	$498M	$575M

Bilanço 29

XRAY için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$326M	$272M	$334M	$365M	$339M	$438M	$405M	$310M	$321M	$384M	$285M	$152M
Inventory	$642M	$564M	$624M	$627M	$515M	$476M	$562M	$599M	$623M	$517M	$340M	$387M
Prepaid Expense	$367M	$354M	$320M	$269M	$248M	$217M	$251M	$278M	$313M	$206M	$172M	$242M
Other Current Assets	$150M	$153M	$113M	$88M	$84M	$67M	$84M	$123M	·	·	·	·
Current Assets	$2.02B	$1.75B	$1.97B	$1.89B	$1.85B	$1.80B	$2.00B	$1.89B	$2.00B	$1.74B	$1.20B	$1.21B
PP&E (Net)	·	·	$800M	$761M	$773M	$791M	$802M	$871M	$876M	$800M	$559M	$589M
PP&E (Gross)	·	·	·	·	·	$2.18B	$2.04B	$2.08B	$2.07B	$1.85B	$1.34B	$1.37B
Accum. Depreciation	·	·	·	·	·	$1.39B	$1.23B	$1.21B	$1.20B	$1.06B	$784M	$782M
Goodwill	$1.15B	$1.60B	$2.44B	$2.69B	$3.98B	$3.99B	$3.40B	$3.43B	$4.54B	$5.95B	$1.99B	$2.09B
Intangibles	$974M	$1.21B	$1.71B	$1.90B	$2.32B	$2.50B	$2.18B	$2.42B	$2.80B	$2.96B	$601M	$671M
Other Non-current Assets	$284M	$301M	$276M	$198M	$121M	$95M	$69M	$77M	$156M	$103M	$59M	$91M
Total Assets	$5.43B	$5.75B	$7.37B	$7.64B	$9.24B	$9.35B	$8.60B	$8.69B	$10.37B	$11.56B	$4.40B	$4.65B
Accounts Payable	$300M	$241M	$305M	$279M	$262M	$302M	$308M	$284M	$284M	$223M	$134M	$133M
Accrued Liabilities	$700M	$754M	$749M	$727M	$760M	$712M	$629M	$579M	$586M	$463M	$310M	$379M
Current Liabilities	$1.34B	$1.59B	$1.43B	$1.17B	$1.26B	$1.37B	$995M	$1.01B	$954M	$768M	$476M	$653M
Capital Leases	$93M	$91M	$125M	$149M	$149M	$130M	$120M	·	·	·	·	·
Deferred Tax	$94M	$129M	$228M	$287M	$391M	$381M	$480M	$553M	$718M	$752M	$160M	$166M
Other Non-current Liabilities	$544M	$415M	$502M	$399M	$528M	$554M	$480M	$423M	$462M	$400M	$286M	$356M
Total Liabilities	$4.09B	$3.81B	$4.08B	$3.83B	$4.24B	$4.42B	$3.51B	$3.55B	$3.75B	$3.43B	$2.06B	$2.32B
Long-term Debt	$2.28B	$1.75B	$1.91B	$1.87B	$1.92B	$2.28B	$1.44B	$1.58B	$1.63B	$1.53B	$1.15B	$1.26B
Total Debt	$2.24B	$1.71B	$1.87B	$1M	$1M	$2.27B	$1.43B	$1.58B	$1.62B	$1.52B	$1.15B	$1.26B
Common Stock	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$2M
Paid-in Capital	$6.64B	$6.64B	$6.64B	$6.63B	$6.61B	$6.60B	$6.59B	$6.52B	$6.54B	$6.52B	$238M	$222M
Retained Earnings	$-1.56B	$-835M	$205M	$456M	$1.51B	$1.20B	$1.40B	$1.23B	$2.32B	$3.95B	$3.59B	$3.38B
Treasury Stock	$3.10B	$3.14B	$2.92B	$2.65B	$2.54B	$2.41B	$2.30B	$2.15B	$1.96B	$1.65B	$898M	$842M
AOCI	$-639M	$-730M	$-636M	$-628M	$-592M	$-464M	$-600M	$-479M	$-291M	$-706M	$-594M	$-441M
Stockholders' Equity	$1.34B	$1.94B	$3.29B	$3.81B	$5.00B	$4.93B	$5.09B	$5.12B	$6.62B	$8.11B	$2.34B	$2.32B
Liabilities + Equity	$5.43B	$5.75B	$7.37B	$7.64B	$9.24B	$9.35B	$8.60B	$8.69B	$10.37B	$11.56B	$4.40B	$4.65B
Shares Outstanding	199,600,000	198,800,000	207,200,000	215,200,000	217,400,000	218,700,000	221,300,000	223,000,000	226,800,000	230,100,000	140,100,000	140,900,000

Nakit Akışı 19

XRAY için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$352M	$349M	$343M	$328M	$347M	$334M	$323M	$331M	$316M	$272M	$123M	$129M
Stock-based Comp	$33M	$39M	$46M	$59M	$48M	$47M	$66M	$21M	$48M	$41M	$26M	$25M
Deferred Tax	$30M	$-136M	$-130M	$-228M	$-25M	$-62M	$-40M	$-62M	$-144M	$-110M	$27M	$18M
Amort. of Intangibles	$211M	$216M	$211M	$209M	$222M	$192M	$190M	$198M	$189M	$155M	$44M	$48M
Restructuring	$24M	$53M	$67M	$14M	$17M	·	$34M	$32M	$55M	$21M	$61M	$10M
Other Non-cash	$418M	$1.12B	$250M	$1.31B	$-124M	$401M	$18M	$1.22B	$1.93B	$-69M	$70M	$66M
Operating Cash Flow	$235M	$461M	$377M	$517M	$657M	$649M	$639M	$500M	$602M	$563M	$497M	$560M
CapEx	$131M	$180M	$149M	$149M	$142M	$87M	$123M	$183M	$144M	$125M	$72M	$100M
Investing Cash Flow	$-132M	$-197M	$-89M	$-138M	$-358M	$-1.11B	$-69M	$-253M	$-286M	$60M	$-55M	$-139M
Debt Issued	$553M	$1M	$0	$6M	$16M	·	·	·	·	·	·	·
Net Debt Issued	$406M	$-87M	$-7M	$-2M	$-297M	$-701M	$-251M	$-9M	$-17M	$-878M	$-268M	$-199M
Stock Repurchased	$0	$250M	$300M	$150M	$200M	$140M	$260M	$250M	$401M	$814M	$113M	$163M
Net Stock Activity	$0	$-250M	$-300M	$-150M	$-200M	$-140M	$-260M	$-250M	$-401M	$-814M	$-113M	$-163M
Dividends Paid	$128M	$126M	$116M	$104M	$92M	$88M	$81M	$79M	$78M	$65M	$40M	$37M
Financing Cash Flow	$-80M	$-302M	$-307M	$-329M	$-379M	$476M	$-472M	$-250M	$-401M	$-526M	$-303M	$-336M
Net Change in Cash	$54M	$-62M	$-31M	$26M	$-99M	$33M	$95M	$-11M	$-63M	$99M	$133M	$77M
Taxes Paid	$71M	$74M	$177M	$122M	$148M	$82M	$112M	$105M	$123M	·	·	·
Free Cash Flow	$104M	$281M	$228M	$368M	$515M	$548M	$510M	$317M	$458M	$438M	$425M	$461M
Levered FCF	·	·	$167M	·	·	$482M	$488M	$278M	$421M	$403M	$383M	$423M

Kârlılık 8

XRAY için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	50.0%	51.6%	52.6%	54.2%	55.5%	49.6%	53.7%	51.9%	54.8%	·	·	54.7%
Operating Margin	-11.5%	-23.2%	-2.1%	-23.9%	14.4%	-0.36%	9.0%	-24.0%	-39.1%	·	·	15.2%
Net Margin	-16.2%	-24.0%	-3.3%	-24.2%	9.7%	-2.5%	6.5%	-25.4%	-38.8%	·	·	11.1%
Pretax Margin	-13.2%	-24.7%	-4.4%	-26.9%	12.9%	-1.8%	8.6%	-24.0%	-40.2%	·	·	13.8%
EBITDA Margin	-1.9%	-14.0%	6.5%	-15.5%	22.6%	9.6%	17.0%	-15.7%	-31.2%	·	·	19.7%
ROA	-10.7%	-13.9%	-1.8%	·	·	-0.93%	3.0%	-10.6%	-14.1%	5.3%	5.5%	6.6%
ROE	-36.4%	-34.8%	-3.7%	·	·	-1.7%	5.1%	-17.2%	-21.0%	8.2%	10.8%	13.3%
ROIC	-14.5%	-23.4%	-1.2%	-84374.4%	45851.0%	-0.23%	4.2%	-15.1%	-18.3%	4.6%	8.2%	9.9%

Likidite ve Solventlik 5

XRAY için Yıllık Likidite ve Solventlik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.5	1.1	1.4	·	·	1.4	2.0	1.9	2.1	2.4	2.5	1.8
Quick Ratio	0.2	0.2	0.2	·	·	0.3	0.4	0.3	0.3	0.5	0.6	0.2
Debt / Equity	1.7	0.9	0.6	·	·	0.5	0.3	0.3	0.2	0.2	0.5	0.5
LT Debt / Equity	1.5	0.8	0.5	·	·	0.4	0.3	0.3	0.2	0.2	0.5	0.5
Interest Coverage	·	·	-1.0	·	·	-0.2	12.3	-25.7	-40.8	12.7	6.7	9.5

Verimlilik 2

XRAY için Yıllık Verimlilik verileri
Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover		0.7	0.6	0.5	·	·	0.4	0.5	0.4	0.4	0.0	0.0	0.6
Inventory Turnover		3.1	3.1	3.0	·	·	3.3	3.2	3.1	3.2	4.1	3.2	3.2

Hisse Başına 7

XRAY için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$6.71	$9.77	$15.89	·	·	$22.71	$23.01	$22.96	$29.17	$35.26	$16.69	·
Revenue / Share	$18.46	$18.67	$18.70	$18.20	$19.21	$15.25	$17.96	$17.77	$17.41	$0.00	$0.00	$20.27
Cash Flow / Share	$1.18	$2.27	$1.78	$2.40	$2.98	$2.90	$2.82	$2.23	$2.62	$2.54	$3.49	$3.89
Cash / Share	$1.63	$1.37	$1.61	·	·	$2.00	$1.83	$1.39	$1.41	$1.67	$2.03	·
Dividend / Share	$1	$1	$1	$0	$0	$0	$0	$0	$0	$0	$0	$0
Dividend Paid / Share	·	·	·	$0	$0	$0	$0	$0	$0	$0	$0	$0
EPS (TTM)	$-3.00	$-4.48	$-0.62	$-4.41	$1.87	$-0.33	$1.14	$-4.51	$-6.76	$1.94	$1.76	$2.24

Büyüme Oranları 4

XRAY için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	-3.0%	-4.3%	1.1%	-7.3%	26.7%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-2.1%	-3.6%	5.9%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	2.0%	·	·	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	7.8%	·	·	·	·	·	·	·	·	·	·	·

Değerleme (TTM) 16

XRAY için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$3.68B	$3.79B	$3.96B	$3.92B	$4.23B	$3.34B	$4.02B	$3.99B	$3.99B	$3.75B	$2.67B	$0
Net Income TTM	$-598M	$-910M	$-132M	$-950M	$411M	$-73M	$256M	$-1.01B	$-1.55B	$430M	$251M	$323M
Market Cap	$2.28B	$3.77B	$7.37B	·	·	$11.45B	$12.52B	$8.30B	$14.93B	$13.28B	$8.53B	·
Enterprise Value	$4.20B	$5.22B	$8.91B	·	·	$13.29B	$13.55B	$9.56B	$16.23B	$14.42B	$9.39B	·
P/E	-3.8	-4.2	-57.4	-7.2	29.8	-158.7	49.6	-8.3	-9.7	29.8	34.6	23.8
P/S	0.6	1.0	1.9	·	·	3.4	3.1	2.1	3.7	3.5	3.2	·
P/B	1.7	1.9	2.2	·	·	2.3	2.5	1.6	2.3	1.6	3.6	·
P / Cash Flow	9.7	8.2	19.6	·	·	18.0	19.8	16.6	24.8	23.6	17.1	·
P / FCF	21.9	13.4	32.3	·	·	20.9	24.6	26.2	32.6	30.3	20.0	·
EV / EBITDA	-60.0	-9.8	34.5	·	·	41.3	19.8	-15.2	-13.0	19.9	18.9	·
EV / FCF	40.4	18.6	39.1	·	·	24.2	26.6	30.1	35.5	32.9	22.1	·
EV / Revenue	1.1	1.4	2.2	·	·	4.0	3.4	2.4	4.1	3.9	3.5	·
Dividend Yield	5.6%	3.3%	1.6%	·	·	0.77%	0.65%	0.95%	0.52%	0.49%	0.47%	·
Earnings Yield	-26.2%	-23.6%	-1.7%	-13.9%	3.4%	-0.63%	2.0%	-12.1%	-10.3%	3.4%	2.9%	4.2%
Payout Ratio	-21.4%	-13.9%	-87.9%	-10.9%	22.4%	-106.0%	30.8%	-7.8%	-5.1%	15.0%	15.9%	11.6%
Annual Payout	$128M	$126M	$116M	$104M	$92M	$88M	$81M	$79M	$78M	$65M	$40M	$37M

Gelir Tablosu 16

XRAY için Çeyreklik Gelir Tablosu verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$880M	$961M	$904M	$936M	$879M	$905M	$951M	$984M	$953M	$1.01B	$947M	$1.03B	$978M	$983M	$947M	$1.02B
Cost of Revenue	$453M	$518M	$463M	$446M	$413M	$459M	$456M	$473M	$447M	$490M	$452M	$478M	$459M	$466M	$439M	$442M
Gross Profit	$427M	$443M	$441M	$490M	$466M	$446M	$495M	$511M	$506M	$522M	$495M	$550M	$519M	$517M	$508M	$581M
R&D Expense	$44M	$40M	$37M	$37M	$36M	$42M	$40M	$41M	$42M	$43M	$46M	$49M	$46M	$43M	$41M	$45M
SG&A Expense	$351M	$383M	$355M	$342M	$358M	$401M	$390M	$399M	$415M	$409M	$372M	$416M	$416M	$402M	$401M	$410M
Operating Income	$-35M	$-139M	$-218M	$-128M	$63M	$-509M	$-462M	$50M	$42M	$73M	$-236M	$80M	$-2M	$65M	$-1.22B	$119M
Interest Expense	·	·	·	·	·	·	·	·	$18M	·	$18M	$21M	$20M	·	$14M	$15M
Other Non-op	$17M	$14M	$11M	$-1M	$0	$2M	$2M	$1M	$7M	$4M	$5M	$-12M	$-6M	$-33M	$-9M	$-13M
Pretax Income	$-42M	$-147M	$-230M	$-153M	$44M	$-523M	$-478M	$34M	$31M	$57M	$-250M	$46M	$-28M	$8M	$-1.24B	$91M
Income Tax	$-32M	$-2M	$198M	$-109M	$25M	$-95M	$17M	$38M	$14M	$-15M	$16M	$-39M	$-5M	$23M	$-164M	$18M
Net Income	$-10M	$-146M	$-427M	$-45M	$20M	$-430M	$-494M	$-4M	$18M	$67M	$-266M	$86M	$-19M	$-15M	$-1.08B	$73M
EPS (Basic)	$-0.05	$-0.74	$-2.14	$-0.22	$0.10	$-2.09	$-2.46	$-0.02	$0.09	$0.31	$-1.25	$0.41	$-0.09	$-0.06	$-5.01	$0.34
EPS (Diluted)	$-0.05	$-0.74	$-2.14	$-0.22	$0.10	$-2.09	$-2.46	$-0.02	$0.09	$0.32	$-1.25	$0.40	$-0.09	$-0.06	$-5.01	$0.34
Shares (Basic)	199,900,000	-398,500,000	199,500,000	199,300,000	199,100,000	-410,800,000	201,000,000	205,600,000	207,400,000	-426,200,000	211,800,000	211,900,000	214,500,000	-431,300,000	214,900,000	214,900,000
Shares (Diluted)	199,900,000	-399,200,000	199,500,000	199,300,000	199,800,000	-411,900,000	201,000,000	205,600,000	208,500,000	-427,400,000	211,800,000	213,100,000	214,500,000	-432,500,000	214,900,000	215,300,000
EBITDA	$44M	·	$-126M	$-40M	$142M	·	$-462M	$50M	$42M	·	$-236M	$80M	·	·	$-1.22B	$119M

Bilanço 27

XRAY için Çeyreklik Bilanço verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$190M	$326M	$363M	$359M	$398M	$272M	$296M	$279M	$291M	·	$309M	$295M	$318M	·	$418M	$362M
Inventory	$659M	$642M	$686M	$675M	$612M	$564M	$619M	$608M	$613M	·	$651M	$657M	$659M	·	$592M	$581M
Prepaid Expense	$374M	$367M	$369M	$286M	$364M	$354M	$335M	$280M	$342M	·	$304M	$298M	$314M	·	$284M	$281M
Other Current Assets	·	$150M	·	·	·	$153M	·	·	·	·	·	·	·	·	·	·
Current Assets	$1.84B	$2.02B	$2.07B	$1.97B	$1.98B	$1.75B	$1.92B	$1.76B	$1.90B	·	$1.91B	$1.92B	$1.94B	·	$1.94B	$1.89B
PP&E (Net)	·	·	·	·	·	·	$817M	$789M	$782M	·	$753M	$772M	$770M	·	$714M	$744M
Goodwill	$1.14B	$1.15B	$1.27B	$1.53B	$1.63B	$1.60B	$1.94B	$2.39B	$2.40B	·	$2.37B	$2.70B	$2.70B	·	$2.58B	$3.86B
Intangibles	$924M	$974M	$1.06B	$1.13B	$1.21B	$1.21B	$1.54B	$1.56B	$1.62B	·	$1.71B	$1.81B	$1.86B	·	$1.88B	$2.10B
Other Non-current Assets	$321M	$284M	$274M	$463M	$304M	$301M	$263M	$240M	$250M	·	$268M	$256M	$206M	·	$209M	$156M
Total Assets	$5.23B	$5.43B	$5.65B	$6.07B	$6.05B	$5.75B	$6.63B	$6.90B	$7.12B	·	$7.20B	$7.65B	$7.67B	·	$7.52B	$8.95B
Accounts Payable	$259M	$300M	$268M	$268M	$276M	$241M	$297M	$287M	$279M	·	$262M	$265M	$267M	·	$271M	$289M
Accrued Liabilities	$688M	$700M	$712M	$672M	$738M	$754M	$798M	$650M	$681M	·	$732M	$728M	$748M	·	$711M	$688M
Current Liabilities	$1.21B	$1.34B	$1.41B	$1.17B	$1.79B	$1.59B	$1.54B	$1.32B	$1.33B	·	$1.22B	$1.27B	$1.37B	·	$1.30B	$1.24B
Capital Leases	$95M	$93M	$85M	$92M	$88M	$91M	$103M	$113M	$120M	·	$133M	$144M	$144M	·	$154M	$159M
Deferred Tax	$84M	$94M	$95M	$109M	$134M	$129M	$193M	$194M	$214M	·	$249M	$261M	$271M	·	$246M	$409M
Other Non-current Liabilities	$518M	$544M	$573M	$523M	$432M	$415M	$503M	$466M	$454M	·	$427M	$431M	$404M	·	$475M	$494M
Total Liabilities	$3.91B	$4.09B	$4.17B	$4.11B	$4.04B	$3.81B	$4.14B	$3.83B	$3.87B	·	$3.83B	$3.95B	$4.04B	·	$3.91B	$4.11B
Long-term Debt	·	$2.28B	·	·	·	$1.71B	·	·	·	·	·	·	·	·	·	·
Total Debt	$2.01B	·	$2.02B	$2.22B	$1.59B	·	$1.79B	$1.74B	$1.75B	·	$1.80B	$1.84B	·	·	$1.74B	$1.81B
Common Stock	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	·	$3M	$3M	$3M	·	$3M	$3M
Paid-in Capital	$6.62B	$6.64B	$6.64B	$6.64B	$6.63B	$6.64B	$6.64B	$6.63B	$6.64B	·	$6.64B	$6.65B	$6.60B	·	$6.62B	$6.62B
Retained Earnings	$-1.57B	$-1.56B	$-1.39B	$-925M	$-848M	$-835M	$-374M	$152M	$190M	·	$167M	$463M	$407M	·	$498M	$1.60B
Treasury Stock	$3.07B	$3.10B	$3.11B	$3.12B	$3.12B	$3.14B	$3.14B	$3.04B	$2.91B	·	$2.78B	$2.79B	$2.76B	·	$2.66B	$2.67B
AOCI	$-655M	$-639M	$-672M	$-641M	$-659M	$-730M	$-638M	$-677M	$-666M	·	$-657M	$-620M	$-614M	·	$-844M	$-719M
Stockholders' Equity	$1.32B	$1.34B	$1.48B	$1.96B	$2.01B	$1.94B	$2.49B	$3.06B	$3.26B	·	$3.38B	$3.71B	$3.64B	·	$3.61B	$4.84B
Liabilities + Equity	$5.23B	$5.43B	$5.65B	$6.07B	$6.05B	$5.75B	$6.63B	$6.90B	$7.12B	·	$7.20B	$7.65B	$7.67B	·	$7.52B	$8.95B
Shares Outstanding	200,300,000	199,600,000	199,500,000	199,300,000	199,300,000	198,800,000	198,800,000	202,600,000	207,600,000	207,200,000	211,800,000	211,700,000	212,500,000	215,200,000	214,900,000	214,800,000

Nakit Akışı 18

XRAY için Çeyreklik Nakit Akışı verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$79M	$93M	$92M	$88M	$79M	$88M	$89M	$86M	$86M	·	·	·	·	·	·	·
Stock-based Comp	$8M	$8M	$6M	$9M	$10M	$4M	$12M	$12M	$11M	$13M	$2M	$14M	$17M	$12M	$14M	$22M
Deferred Tax	$-60M	$-14M	$180M	$-137M	$1M	$-116M	$-9M	$-2M	$-9M	$-23M	$-24M	$-62M	$-21M	$-8M	$-207M	$1M
Amort. of Intangibles	$41M	$56M	$56M	$54M	$45M	$54M	$54M	$54M	$54M	$52M	$53M	$53M	$53M	$50M	$51M	$53M
Restructuring	$67M	$6M	$5M	$4M	$9M	$8M	$23M	$21M	$1M	$-3M	$6M	$5M	$59M	$1M	$3M	$7M
Other Non-cash	$23M	·	·	·	$-103M	·	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$40M	$101M	$79M	$48M	$7M	$87M	$141M	$208M	$25M	$160M	$134M	$104M	$-21M	$142M	$109M	$173M
CapEx	$52M	$41M	$39M	$32M	$19M	$51M	$43M	$52M	$34M	$40M	$37M	$33M	$39M	$32M	$32M	$41M
Investing Cash Flow	$-53M	$-45M	$-36M	$-34M	$-17M	$-57M	$-47M	$-50M	$-43M	$-20M	$-2M	$-30M	$-37M	$-29M	$-26M	$-40M
Debt Issued	·	$2M	$1M	·	·	$1M	$0	·	·	$-2M	$2M	$0	$0	$-1M	$2M	$0
Net Debt Issued	$-31M	·	·	·	$-2M	·	·	·	$-3M	·	·	·	·	·	·	·
Stock Repurchased	·	$0	$0	·	·	$0	$100M	$150M	$0	$150M	$0	$0	$150M	$0	$150M	$150M
Net Stock Activity	·	·	·	·	·	·	·	·	$0	·	·	·	·	·	·	·
Dividends Paid	$32M	$32M	$32M	$32M	$32M	$31M	$33M	$33M	$29M	$30M	$29M	$30M	$27M	$26M	$27M	$27M
Financing Cash Flow	$-119M	$-99M	$-36M	$-68M	$123M	$-38M	$-79M	$-171M	$-14M	$-128M	$-109M	$-87M	$17M	$-161M	$-6M	$-152M
Net Change in Cash	$-136M	$-37M	$4M	$-39M	$126M	$-24M	$17M	$-12M	$-43M	$25M	$14M	$-23M	$-47M	$-53M	$56M	$-12M
Free Cash Flow	$-12M	·	·	·	$-12M	·	·	·	$-9M	·	·	·	·	·	·	·
Levered FCF	·	·	·	·	·	·	·	·	$-19M	·	·	·	·	·	·	·

Kârlılık 8

XRAY için Çeyreklik Kârlılık verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Gross Margin	48.5%	·	48.8%	52.3%	53.0%	·	52.0%	51.9%	53.1%	·	52.3%	53.5%	·	·	53.6%	56.8%
Operating Margin	-4.0%	·	-24.1%	-13.7%	7.2%	·	-48.6%	5.1%	4.4%	·	-24.9%	7.8%	·	·	-128.6%	11.6%
Net Margin	-1.1%	·	-47.2%	-4.8%	2.3%	·	-51.9%	-0.41%	1.9%	·	-28.1%	8.4%	·	·	-113.7%	7.1%
Pretax Margin	-4.8%	·	-25.4%	-16.4%	5.0%	·	-50.3%	3.5%	3.2%	·	-26.4%	4.5%	·	·	-131.1%	8.9%
EBITDA Margin	5.0%	·	-13.9%	-4.3%	16.2%	·	-48.6%	5.1%	4.4%	·	-24.9%	7.8%	·	·	-128.6%	11.6%
ROA	-0.18%	·	-7.0%	-0.69%	0.30%	·	-7.1%	-0.05%	0.24%	·	-3.6%	1.0%	·	·	-12.8%	0.80%
ROE	-0.60%	·	-21.5%	-1.8%	0.76%	·	-16.8%	-0.12%	0.52%	·	-7.6%	2.0%	·	·	-24.8%	1.5%
ROIC	-0.25%	·	-11.6%	-0.88%	0.76%	·	-11.2%	-0.12%	0.46%	·	-4.9%	2.7%	·	·	-19.8%	1.4%

Likidite ve Solventlik 5

XRAY için Çeyreklik Likidite ve Solventlik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	1.5	·	1.5	1.7	1.1	·	1.2	1.3	1.4	·	1.6	1.5	·	·	1.5	1.5
Quick Ratio	0.2	·	0.3	0.3	0.2	·	0.2	0.2	0.2	·	0.3	0.2	·	·	0.3	0.3
Debt / Equity	1.5	·	1.4	1.1	0.8	·	0.7	0.6	0.5	·	0.5	0.5	·	·	0.5	0.4
LT Debt / Equity	1.5	·	1.4	1.1	0.8	·	0.7	0.6	0.5	·	0.5	0.5	·	·	0.5	0.4
Interest Coverage	·	·	·	·	·	·	·	·	2.3	·	-13.1	3.8	·	·	-87.0	7.9

Verimlilik 2

XRAY için Çeyreklik Verimlilik verileri
Metrik	Eğilim	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover		0.2	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	·	·	0.1	0.1
Inventory Turnover		0.7	·	0.7	0.7	0.7	·	0.7	0.7	0.7	·	0.7	0.8	·	·	0.8	0.8

Hisse Başına 6

XRAY için Çeyreklik Hisse Başına verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$6.58	·	$7.41	$9.83	$10.09	·	$12.53	$15.12	$15.69	·	$15.93	$17.51	·	·	$16.81	$22.52
Revenue / Share	$4.40	·	$4.53	$4.70	$4.40	·	$4.73	$4.79	$4.57	·	$4.47	$4.82	·	·	$4.41	$4.75
Cash Flow / Share	$0.20	·	·	·	$0.04	·	·	·	$0.12	·	·	·	·	·	·	·
Cash / Share	$0.95	·	$1.82	$1.80	$2.00	·	$1.49	$1.38	$1.40	·	$1.46	$1.39	·	·	$1.95	$1.69
Dividend / Share	·	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
EPS (TTM)	$-2.31	·	$-4.72	$-2.60	$-2.29	·	$-3.64	$-0.78	$-0.85	·	$-5.95	$-4.36	$-4.44	·	$-3.81	$1.58

Değerleme (TTM) 14

XRAY için Çeyreklik Değerleme (TTM) verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$3.60B	·	$3.67B	$3.75B	$3.77B	·	$3.83B	$3.91B	$3.91B	·	$3.90B	$3.98B	$3.92B	·	$4.04B	$4.13B
Net Income TTM	$-462M	·	$-946M	$-523M	$-460M	·	$-746M	$-166M	$-181M	·	$-1.28B	$-937M	$-954M	·	$-816M	$345M
Market Cap	$2.32B	·	$2.53B	$3.16B	$2.98B	·	$5.38B	$5.05B	$6.89B	·	$7.24B	$8.47B	·	·	$6.09B	$7.67B
Enterprise Value	$4.14B	·	$4.19B	$5.02B	$4.17B	·	$6.88B	$6.50B	$8.35B	·	$8.73B	$10.02B	·	·	$7.41B	$9.12B
P/E	-5.0	·	-2.7	-6.1	-6.5	·	-7.4	-31.9	-39.0	·	-5.7	-9.2	-8.8	·	-7.4	22.6
P/S	0.6	·	0.7	0.8	0.8	·	1.4	1.3	1.8	·	1.9	2.1	·	·	1.5	1.9
P/B	1.8	·	1.7	1.6	1.5	·	2.2	1.6	2.1	·	2.1	2.3	·	·	1.7	1.6
P / Cash Flow	58.1	·	·	·	425.4	·	·	·	275.6	·	·	·	·	·	·	·
P / FCF	-193.6	·	·	·	-248.1	·	·	·	-765.6	·	·	·	·	·	·	·
EV / EBITDA	94.1	·	-33.2	-125.6	29.4	·	-14.9	130.1	198.7	·	-37.0	125.2	·	·	-6.1	76.6
EV / FCF	-345.0	·	·	·	-347.7	·	·	·	-927.4	·	·	·	·	·	·	·
EV / Revenue	1.2	·	1.1	1.3	1.1	·	1.8	1.7	2.1	·	2.2	2.5	·	·	1.8	2.2
Earnings Yield	-19.9%	·	-37.2%	-16.4%	-15.3%	·	-13.5%	-3.1%	-2.6%	·	-17.4%	-10.9%	-11.3%	·	-13.4%	4.4%
Payout Ratio	-320.0%	·	·	·	160.0%	·	·	·	161.1%	·	·	·	·	·	·	·

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$3.68B	$3.79B	$3.96B	$3.92B	$4.23B
Brüt Kâr Marjı %	50.0%	51.6%	52.6%	54.2%	55.5%
Faaliyet Kâr Marjı %	-11.5%	-23.2%	-2.1%	-23.9%	14.4%
Net Gelir	$-598M	$-910M	$-132M	$-950M	$411M
Seyreltilmiş Hisse Başı Kâr	$-3.00	$-4.48	$-0.62	$-4.41	$1.87

Bilanço

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Borç / Öz Sermaye	1.7	0.9	0.6	—	—
Cari Oran	1.5	1.1	1.4	—	—
Cari Oran	0.2	0.2	0.2	—	—

Nakit Akışı

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$104M	$281M	$228M	$368M	$515M

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

XRAY Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

XRAY Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

XRAY Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar